Dr Marston Curtis Martin, OD | |
925 Mally St, Tuscaloosa, AL 35405-8785 | |
(205) 344-5111 | |
(205) 344-5004 |
Full Name | Dr Marston Curtis Martin |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 28 Years |
Location | 925 Mally St, Tuscaloosa, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285607879 | NPI | - | NPPES |
000034313 | Medicaid | AL | |
051034313 | Other | AL | BLUE CROSS BLUE SHIELD |
3919300001 | Other | AL | DMERC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | S846TA372 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Martin Family Eyecare | 4981624137 | 2 |
News Archive
The current data confirms previous health economic evaluations: If patients with chronic heart failure are receive telemedical supervision, this means that they will require less and shorter hospital care. In this study hospital expenses dropped by around 70 percent in a year.
A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
SEATTLE-Group Health Research Institute is the new name of Group Health Center for Health Studies. Since 1983, it has been doing research to improve health and health care for all. The Institute is the research arm of Group Health Cooperative, and it is changing its name to reflect this relationship more clearly.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
› Verified 8 days ago
Provider Name | Martin Family Eyecare |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1225207889 PECOS PAC ID: 4981624137 Enrollment ID: O20051201001002 |
News Archive
The current data confirms previous health economic evaluations: If patients with chronic heart failure are receive telemedical supervision, this means that they will require less and shorter hospital care. In this study hospital expenses dropped by around 70 percent in a year.
A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
SEATTLE-Group Health Research Institute is the new name of Group Health Center for Health Studies. Since 1983, it has been doing research to improve health and health care for all. The Institute is the research arm of Group Health Cooperative, and it is changing its name to reflect this relationship more clearly.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Marston Curtis Martin, OD 925 Mally St, Tuscaloosa, AL 35405-8785 Ph: (205) 344-5111 | Dr Marston Curtis Martin, OD 925 Mally St, Tuscaloosa, AL 35405-8785 Ph: (205) 344-5111 |
News Archive
The current data confirms previous health economic evaluations: If patients with chronic heart failure are receive telemedical supervision, this means that they will require less and shorter hospital care. In this study hospital expenses dropped by around 70 percent in a year.
A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
SEATTLE-Group Health Research Institute is the new name of Group Health Center for Health Studies. Since 1983, it has been doing research to improve health and health care for all. The Institute is the research arm of Group Health Cooperative, and it is changing its name to reflect this relationship more clearly.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
› Verified 8 days ago
Dr. Haley Henson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 925 Mally St, Tuscaloosa, AL 35405 Phone: 205-344-5111 | |
Dr. Wesley A Dubose, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1800 Mcfarland Blvd E, Suite 406, Tuscaloosa, AL 35404 Phone: 205-342-0745 Fax: 205-345-0475 | |
Global Eye Care, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 1501 Skyland Blvd E, Tuscaloosa, AL 35405 Phone: 205-750-8529 Fax: 205-750-8971 | |
Dr. Carrie Elizabeth Smith, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 535 Jack Warner Pkwy Ne Ste B1, Tuscaloosa, AL 35404 Phone: 205-556-2121 Fax: 205-554-0152 | |
Dr. Nathan A Whitaker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Vamc, Tuscaloosa, AL 35404 Phone: 205-554-2822 | |
Dr. Colleen Stanley Dent, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1401 Skyland Blvd E, In Sams Club Optical, Tuscaloosa, AL 35405 Phone: 205-345-3893 Fax: 205-345-3896 | |
Dr. Blaze Sammon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3501 Mcfarland Blvd E, Tuscaloosa, AL 35405 Phone: 205-556-7950 |